BioSpace News Archive

The oncology is rapidly embracing proton therapy for improving treatment outcomes in various types of cancer.

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Australia’s Therapeutic Goods Administration has granted approval for provisional registration of NVX-CoV2373, Novavax’ COVID-19 vaccine, for active immunization to prevent coronavirus disease 2019 caused by SARS-CoV-2 in individuals 18 years of age and older.

The expanding number of street mishaps across the globe is one of the main considerations driving the market.

E-prescription is a type of electronic prescribing technology that enables doctors to become paperless by transmitting prescriptions in a digital format rather than handwriting them.

Bacterial drugs are the substances that may destroy or constrain the microorganism growth such as bacteria.

StemCultures today announced the launch of FGF2 DISC™ devices which consist of biodegradable StemBeads® loaded with recombinant human fibroblast growth factor 2 (FGF2) embedded in an inert non-biodegradable, biocompatible hydrogel device.

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced that Dr. Ripal Gandhi, M.D., FSIR, FSVM, a Principal Investigator in the Company’s Phase 3 TIGeR-PaC study, presented ‘Trans-arterial Treatment Option in Pancreas Cancer’ at the recent 2022 SPECTRUM Conference.

Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, announced today the publication of a new peer-reviewed study analyzing the efficacy, safety and sustainability of remote electrical neuromodulation (REN) as a standalone, and medication adjunct, treatment of migraine.

Predicine, a global molecular insights company, announced today that it has appointed Clint Webb as its new General Counsel (GC).

Increasing application of chromatography experiments, rising demand for monoclonal antibodies, and rising R&D expenditure and investment are key factors driving market growth.